SEC 13F Intelligence

North Growth Management Ltd. / BSX

North Growth Management Ltd.’s Boston Scientific Corp Position

Does North Growth Management Ltd. own Boston Scientific Corp (BSX)? Not currently — the last reported position was 170.0K shares worth $7M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q3 2021
Shares
170.0K
% of Portfolio
+1.30%
Quarters Held
11
position exited

Position History BSX

Reported value by quarter
Q1 ’19: $9MQ1 ’19Q2 ’19: $10MQ3 ’19: $10MQ3 ’19Q4 ’19: $11MQ1 ’20: $7MQ1 ’20Q2 ’20: $7MQ3 ’20: $7MQ3 ’20Q4 ’20: $6MQ1 ’21: $7MQ1 ’21Q2 ’21: $7MQ3 ’21: $7MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021170.0K$7M+1.30%
Q2 2021169.0K$7M+1.18%
Q1 2021169.0K$7M+1.15%
Q4 2020169.0K$6M+1.24%
Q3 2020181.0K$7M+1.52%
Q2 2020201.0K$7M+1.69%
Q1 2020217.0K$7M+1.99%
Q4 2019243.0K$11M+2.46%
Q3 2019243.0K$10M+2.38%
Q2 2019243.0K$10M+2.58%
Q1 2019243.0K$9M+2.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See North Growth Management Ltd.’s full portfolio or all institutional holders of BSX.